News

Biofil Chemicals & Pharmaceuticals informs about revised disclosures

Biofil Chemicals & Pharmaceuticals has informed that the Exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Starline Equifin.

The above information is a part of company’s filings submitted to BSE.